abstract |
The present invention relates to novel piperazine amide derivatives of formula (I) as well as physiologically acceptable salts thereof. Formula I In this formula, R 1 to R 11 , W, X and Y are as defined in the specification and claims. The compound binds to LXR alpha and LXR beta and can be used as a medicament. |